• Hologic Inc HOLX.OQ reported quarterly adjusted earnings of $1.03​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 98 cents. The mean expectation of eighteen analysts for the quarter was for earnings of $1.02 per share. Wall Street expected results to range from 99 cents to $1.03 per share.

• Revenue rose 0.9% to $1.02 billion from a year ago; analysts expected $1.02 billion.

• Hologic Inc's reported EPS for the quarter was 87 cents​.

• The company reported quarterly net income of $201 million.

• Hologic Inc shares had fallen by 0.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.6% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 13 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."

Wall Street's median 12-month price target for Hologic Inc is $85.00

This summary was machine generated from LSEG data February 5 at 10:42 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)